Europe tightens controls on drug precursors
The European Parliament has adopted new measures to control the trade in two compounds used for both legitimate pharmaceutical applications and the manufacture of illicit drugs, writes Phil Taylor.
The European Parliament has adopted new measures to control the trade in two compounds used for both legitimate pharmaceutical applications and the manufacture of illicit drugs, writes Phil Taylor.
A new flexible coupling promises to make the handling of toxic and high potency compounds safer, and is a cheaper option than current rigid containment devices, according to its manufacturer.
Researchers at Harvard Medical School in the US have developed a way to rapidly screen compounds for potential therapeutic activity in diseases where current screening methods are limited.